UBS Group’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-164,000
Closed -$5.58M 9757
2023
Q3
$5.58M Buy
164,000
+14,000
+9% +$529K ﹤0.01% 2470
2023
Q2
$5.9M Buy
150,000
+80,000
+114% +$2.89M ﹤0.01% 2422
2023
Q1
$2.25M Hold
70,000
﹤0.01% 3294
2022
Q4
$2.18M Buy
+70,000
New +$2.53M ﹤0.01% 3311

Other funds holding PGNY

UBS Group's PGNY Position: Q2 2026 in Review

UBS Group reduced its Progyny (PGNY) stake by 18% in Q2 2026, selling an estimated $1.49M and leaving 307,970 shares worth $8.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3580.

UBS Group first reported a position in PGNY in Q4 2019 and has held it in 27 quarters since. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • UBS Group held 307,970 shares of Progyny worth $8.88M as of Q2 2026.
  • UBS Group sold 66,474 Progyny shares in Q2 2026, an estimated $1.49M.
  • Progyny made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3580 holding.
  • UBS Group first reported a position in Progyny in Q4 2019 and has held it in 27 quarters since.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.